1 study on GHRH-LA1 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides compelling evidence that peptidomimetic long-acting GHRH agonists can effectively promote tissue perfusion and reduce limb loss in models of severe ischemia. The observed improvements in blood flow…
Free, no account — handy when you're working with GHRH-LA1.